Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Beclomethasone dipropionate 200 g per metered dose Inhalation, powder Orion Corporation, Espoo, Finland Atomide Easyhaler Oestradiol 0.312 mg/cm (25 g/24 hours) Transdermal patch 3M Pharmaceuticals, Northridge, California, United States of America Climara 25 Oestradiol 0.312 mg/cm (75 g/24 hours) Transdermal patch 3M Pharmaceuticals, Northridge, California, United States of America Climara 75 Dextromethorphan hydrobromide 1 mg/mL Syrup PSM Healthcare Limited, Wiri, Auckland Dextromethorphan Cough Mixture Ammonium chloride 25 mg/mL, diphenhydramine hydrochloride 2.5 mg/mL Syrup PSM Healthcare Limited, Wiri, Auckland Diphenhydramine Cough Mixture Oestradiol hemihydrate 0.312 mg/cm (25 g/24 hours) Transdermal patch 3M Pharmaceuticals, Northridge, California, United States of America Femtran 25 Oestradiol hemihydrate 0.312 mg/cm (75 g/24 hours) Transdermal patch 3M Pharmaceuticals, Northridge, California, United States of America Femtran 75 Hydrocortisone 1 % w/w, miconazole 2 % w/w Cream, topical Ego Pharmaceuticals Pty Limited, Braeside, Victoria, Australia Fungocort Opium tincture 1 % 16.08 mg/mL, squill oxymel (as EFM oxymel squill 125:1000) 44.4 mg/mL Linctus PSM Healthcare Limited, Wiri, Auckland Gees Linctus Morphine sulphate 10 mg Capsule, modified release Faulding Pharmaceuticals, Salisbury, South Australia, Australia Kapanol Opti-Plus: Pancreatin equivalent to 950 g Tyrosine/min/mL Opti-Free: Citric acid monohydrate 0.021 % w/v, disodium citrate dihydrate 0.56 % w/v, sodium chloride 0.516 % w/v Solutions, contact lens Opti-Plus: Alcon Cusi SA., Alcobendas, Madrid, Spain Opti-Free: Alcon Cusi SA., Alcobendas, Madrid, Spain; and Alcon Laboratories Inc., Fort Worth, Texas, United States of America Opti-Free / Opti-Plus Combination Pack Paracetamol 500 mg Suppository Rice Steele & Co Limited, Tallaght, Dublin, Eire Paralink Ranitidine hydrochloride 84 mg equivalent to 75 mg ranitidine base Tablet, film coated Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom; and Glaxo Wellcome SA., Aranda de Duero, Spain Zantax 75 Dated this 26th day of March 1999. GILLIAN GREW, Chief Advisor, Regulation and Safety (acting), pursuant to delegation given by the Minister of Health on the 20th day of February 1997.